Mannkind (MNKD) Cash from Financing Activities (2010 - 2026)
Mannkind (MNKD) reported Cash from Financing Activities of -$35.4 million for Q1 2026, down 2647.19% year-over-year from $1.4 million in Q1 2025, and down 114.31% on a QoQ basis from $247.4 million in Q4 2025.
Mannkind (MNKD) has 17 years of Cash from Financing Activities data on file, last reported at -$35.4 million in Q1 2026.
- Quarterly Cash from Financing Activities fell 2647.19% year-over-year to -$35.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $278.3 million (up 310.2% YoY) and the FY2025 annual result came in at $315.1 million, up 329.55% from the prior year.
- Cash from Financing Activities retreated to -$35.4 million in Q1 2026 per MNKD's latest filing, from $247.4 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $247.4 million in Q4 2025 and bottomed at -$86.9 million in Q4 2024.
- The 5-year median for Cash from Financing Activities is -$283000.0 (2023), against an average of $17.7 million.
- The widest annual swing landed in 2023, when Cash from Financing Activities surged 4915.26%; it then slumped 2647.19% in 2026.
- Tracing MNKD's Cash from Financing Activities over 5 years: stood at $2.8 million in 2022, then surged by 4915.26% to $141.7 million in 2023, then slumped by 161.33% to -$86.9 million in 2024, then jumped by 384.71% to $247.4 million in 2025, then slumped by 114.31% to -$35.4 million in 2026.
- Per Business Quant, the three latest MNKD Cash from Financing Activities figures stand at -$35.4 million (Q1 2026), $247.4 million (Q4 2025), and $71.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -802.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.71 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | -35.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.41 Mn |
| Mar 31, 2026 | -35.41 Mn |
| Dec 31, 2025 | 247.41 Mn |
| Dec 31, 2025 | 247.41 Mn |
| Sep 30, 2025 | 71.81 Mn |
| Sep 30, 2025 | 71.81 Mn |
| Jun 30, 2025 | -5.51 Mn |
| Jun 30, 2025 | -5.51 Mn |
| Mar 31, 2025 | 1.39 Mn |
| Mar 31, 2025 | 1.39 Mn |
| Dec 31, 2024 | -86.90 Mn |
| Dec 31, 2024 | -86.90 Mn |
| Sep 30, 2024 | -2.34 Mn |
| Sep 30, 2024 | -2.34 Mn |
| Jun 30, 2024 | -44.55 Mn |
| Jun 30, 2024 | -44.55 Mn |
| Mar 31, 2024 | -3.47 Mn |
| Mar 31, 2024 | -3.47 Mn |
| Dec 31, 2023 | 141.68 Mn |
| Dec 31, 2023 | 141.68 Mn |
| Sep 30, 2023 | -283,000.00 |
| Sep 30, 2023 | -283,000.00 |
| Jun 30, 2023 | -5.95 Mn |
| Jun 30, 2023 | -5.95 Mn |
| Mar 31, 2023 | 1.15 Mn |
| Mar 31, 2023 | 1.15 Mn |
| Dec 31, 2022 | 2.83 Mn |
| Dec 31, 2022 | 2.83 Mn |
| Sep 30, 2022 | 19.53 Mn |
| Sep 30, 2022 | 19.53 Mn |
| Jun 30, 2022 | -1.78 Mn |
| Jun 30, 2022 | -1.78 Mn |
| Mar 31, 2022 | 813,000.00 |
| Mar 31, 2022 | 813,000.00 |
| Dec 31, 2021 | 97.37 Mn |
| Dec 31, 2021 | 97.37 Mn |
| Sep 30, 2021 | -590,000.00 |
| Sep 30, 2021 | -590,000.00 |
| Jun 30, 2021 | -51.49 Mn |
| Jun 30, 2021 | -51.49 Mn |
| Mar 31, 2021 | 224.98 Mn |
| Mar 31, 2021 | 224.98 Mn |
| Dec 31, 2020 | 18.69 Mn |
| Dec 31, 2020 | 18.69 Mn |
| Sep 30, 2020 | 2.64 Mn |
| Sep 30, 2020 | 2.64 Mn |
| Jun 30, 2020 | 28.19 Mn |
| Jun 30, 2020 | 28.19 Mn |
| Mar 31, 2020 | 331,000.00 |
| Mar 31, 2020 | 331,000.00 |
| Dec 31, 2019 | 5.04 Mn |
| Dec 31, 2019 | 5.04 Mn |
| Sep 30, 2019 | 65.50 Mn |
| Sep 30, 2019 | 65.50 Mn |
| Jun 30, 2019 | -676,000.00 |
| Jun 30, 2019 | -676,000.00 |
| Mar 31, 2019 | 3,000.00 |
| Mar 31, 2019 | 3,000.00 |
| Dec 31, 2018 | 35.97 Mn |
| Dec 31, 2018 | 35.97 Mn |
| Sep 30, 2018 | -1.82 Mn |
| Sep 30, 2018 | -1.82 Mn |
| Jun 30, 2018 | 26.62 Mn |
| Jun 30, 2018 | 26.62 Mn |
| Mar 31, 2018 | 528,000.00 |
| Mar 31, 2018 | 528,000.00 |
| Dec 31, 2017 | 58.24 Mn |
| Dec 31, 2017 | 58.24 Mn |
| Sep 30, 2017 | -22,000.00 |
| Sep 30, 2017 | -22,000.00 |
| Jun 30, 2017 | 15.42 Mn |
| Jun 30, 2017 | 15.42 Mn |
| Mar 31, 2017 | -75,000.00 |
| Mar 31, 2017 | -75,000.00 |
| Dec 31, 2016 | 117,000.00 |
| Dec 31, 2016 | 117,000.00 |
| Sep 30, 2016 | -5.13 Mn |
| Sep 30, 2016 | -5.13 Mn |
| Jun 30, 2016 | 47.59 Mn |
| Jun 30, 2016 | 47.59 Mn |
| Mar 31, 2016 | 464,000.00 |
| Mar 31, 2016 | 464,000.00 |
| Dec 31, 2015 | 49.01 Mn |
| Dec 31, 2015 | 49.01 Mn |
| Sep 30, 2015 | -53.21 Mn |
| Sep 30, 2015 | -53.21 Mn |
| Jun 30, 2015 | 8.69 Mn |
| Jun 30, 2015 | 8.69 Mn |
| Mar 31, 2015 | 1.19 Mn |
| Mar 31, 2015 | 1.19 Mn |
| Dec 31, 2014 | -1.67 Mn |
| Dec 31, 2014 | -1.67 Mn |
| Sep 30, 2014 | 31.23 Mn |
| Sep 30, 2014 | 31.23 Mn |
| Jun 30, 2014 | 37.13 Mn |
| Jun 30, 2014 | 37.13 Mn |
| Mar 31, 2014 | 3.37 Mn |
| Mar 31, 2014 | 3.37 Mn |
| Dec 31, 2013 | 17.20 Mn |
| Dec 31, 2013 | 17.20 Mn |
| Sep 30, 2013 | 98.41 Mn |
| Sep 30, 2013 | 98.41 Mn |
| Jun 30, 2013 | 30.40 Mn |
| Jun 30, 2013 | 30.40 Mn |
| Mar 31, 2013 | -349,000.00 |
| Mar 31, 2013 | -349,000.00 |
| Dec 31, 2012 | 88.23 Mn |
| Dec 31, 2012 | 88.23 Mn |
| Sep 30, 2012 | 4.51 Mn |
| Sep 30, 2012 | 4.51 Mn |
| Jun 30, 2012 | 386,000.00 |
| Jun 30, 2012 | 386,000.00 |
| Mar 31, 2012 | 86.45 Mn |
| Mar 31, 2012 | 86.45 Mn |
| Dec 31, 2011 | 375,000.00 |
| Dec 31, 2011 | 375,000.00 |
| Sep 30, 2011 | 34.65 Mn |
| Sep 30, 2011 | 34.65 Mn |
| Jun 30, 2011 | 18.65 Mn |
| Jun 30, 2011 | 18.65 Mn |
| Mar 31, 2011 | 9.72 Mn |
| Mar 31, 2011 | 9.72 Mn |
| Dec 31, 2010 | 15.22 Mn |
| Dec 31, 2010 | 15.22 Mn |
| Sep 30, 2010 | 103.97 Mn |
| Sep 30, 2010 | 103.97 Mn |